Journal of Andrology, Vol. 25, No. 4, July/August 2004
Copyright © American Society of Andrology
Androgen Regulation of JM-27 Is Associated With the Diseased Prostate
UZMA S. SHAH*,
JULIE ARLOTTI*,
RAJIV DHIR
,
,
SUN LU
,
GREGORIO PIROZZI
,
KULKARNI PRAKASH
AND
ROBERT H. GETZENBERG*,
,
From the Departments of * Urology and
Pathology, and
University of Pittsburgh Cancer Institute,
University of Pittsburgh, Pittsburgh, Pennsylvania; and
Gene Logic Inc, Gaithersburg, Maryland.
|
Correspondence to: Dr Robert H. Getzenberg, Department of Urology Research
Laboratories, University of Pittsburgh, Shadyside Medical Center G-40, 5200
Centre Avenue, Pittsburgh, PA 15232. |
Despite intense research efforts, the etiology of prostatic hyperplasia
associated with both benign prostatic hyperplasia (BPH) and prostate cancer
remains poorly understood. Our previous studies using array technology
identified JM-27 as a transcript that is dramatically up-regulated in the
prostates of patients with symptomatic BPH and in normal, adjacent prostatic
regions of patients with prostate cancer. In the present study, using an
extended sample set, we show a correlation between the messenger RNA and
protein expression of JM-27. To investigate the possible functions of this
gene, its expression in the rat prostate was examined by immunoblot analysis
using a polyclonal antibody specific to human JM-27. This antibody reacts with
2 rat polypeptides of 17 kd and 27 kd in size. Whereas the 27-kd form of the
JM-27 protein found in human prostate is selectively expressed in the
dorsolateral lobes of the rat prostate, the 17-kd form is expressed only in
the ventral lobe. Expression of both forms of this protein appears to be
androgen-regulated. There is a time-dependent decrease in expression of the
protein products in the ventral and dorsolateral lobes of the rat prostate
after castration. Administration of exogenous testosterone in castrated
animals maintains protein expression in both lobes. Androgens are believed to
play a central role in prostate growth and development, and therefore, it is
tempting to speculate that JM-27, an androgen-regulated gene, may be involved
in prostatic growth regulation. Further studies are underway to evaluate such
a function for JM-27 in prostatic diseases.
Key words: Benign prostatic hyperplasia, prostate cancer, genes, gene expression
Copyright © 2004 by The American Society of Andrology.